Decellularization technology to remove DNA and other cellular material from tissue, leaving intact an inert acellular matrix upon which patients' cells can repopulate, for use in applications such as wound care, heart valve replacement and knee repair
The potential applications of dCELL® are diverse and address critical clinical needs such as; wound care, heart valve replacement and knee repair.
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Tissue Regenix plus 4749 other startups.